Education
About Us
Working with TipRanks
Follow Us
NeurAxis, Inc. (NRXS)
:NRXS
Earnings Data
Report Date
Nov 24, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.17Last Year’s EPS
-0.25Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflected strong revenue growth and significant milestones achieved, such as FDA indication expansion and favorable CPT code assignments. However, challenges remain with insurance coverage barriers and high discount rates impacting gross margins. The company is in a good financial position with recent fundraising efforts but continues to report net losses.Company Guidance
Significant Revenue Growth
NeurAxis reported a revenue increase of 46% in Q2 2025 compared to Q2 2024, marking the fourth consecutive quarter of double-digit growth.
Milestone Achievements
The company expanded the FDA indication for IB-Stim to functional dyspepsia with nausea symptoms, published NASPGHAN guidelines, and received a Category I CPT code assignment with favorable RVU and reimbursement values.
Increase in Market Opportunity
With the expanded FDA indication, the market opportunity for IB-Stim nearly doubled, covering a wider age range and symptoms.
Strong Financial Position
The company raised $5 million through equity financing and an additional $1 million from stock warrants, with cash on hand of $6 million.
Progress in Medical Policy Coverage
NeurAxis reached about 53 million covered lives for IB-Stim and anticipates further policy coverage expansion.
NRXS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NRXS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 12, 2025 | $2.43 | $2.49 | +2.47% |
May 12, 2025 | $2.00 | $2.32 | +16.00% |
Mar 20, 2025 | $2.29 | $2.27 | -0.87% |
Nov 12, 2024 | $2.50 | $3.16 | +26.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does NeurAxis, Inc. (NRXS) report earnings?
NeurAxis, Inc. (NRXS) is schdueled to report earning on Nov 24, 2025, Before Open (Confirmed).
What is NeurAxis, Inc. (NRXS) earnings time?
NeurAxis, Inc. (NRXS) earnings time is at Nov 24, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NRXS EPS forecast?
NRXS EPS forecast for the fiscal quarter 2025 (Q3) is -0.17.